ERCC2 and gastric cancer: In recent years, many researchers have investigated possible relationships between two ERCC2 polymorphisms, rs13181 and rs1799793, and treatment response and prognosis, which are indicators of chemotherapy efficacy, in patients with gastric cancer [12–24]; however, most of these studies have been inconclusive.